Trial profile

Dampening the Reproductive Axis With Continuous Kisspeptin in PCOS

ClinicalTrials.gov: NCT05971849

Design and population

Sponsor

National Institutes of Health (NIH)

Phase

Phase 1

Design

Open-label mechanistic study

Overall status

Completed

Enrollment

Planned enrollment

—

Actual enrollment

—

Population summary

Women with polycystic ovary syndrome in a small mechanistic study.

Sex eligibility

—

Reproductive and life-stage eligibility

Pregnancy eligibility

—

Lactation eligibility

—

Reproductive-potential requirements

—

Sex-stratification / analysis plan

—

Medicines studied

Kisspeptin

Reproductive neuropeptide pathway modulator

What can and cannot be concluded for women

Conclusions depend on whether women were enrolled in sufficient numbers, whether a sex analysis was prespecified and powered, and what life-stage data were reported. Use the enrollment and analysis details above to judge how far the results can be generalized, and verify the current trial status at ClinicalTrials.gov.

Sources

Primary records

ClinicalTrials.gov
clinical trial registry
Public registry for verifying trial design, enrollment, status, and results.
PubMed
peer reviewed article
Index of peer-reviewed biomedical literature.

Direct registry link: verify status and results at ClinicalTrials.gov.

Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.